Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Genes Brain Behav ; 12(4): 405-13, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23433317

RESUMEN

We recently observed a reliable phenotypic difference in the inflammatory pain sensitivity of a congenic mouse strain compared to its background strain. By constructing and testing subcongenic strains combined with gene-expression assays, we provide evidence for the candidacy of the Yy1 gene - encoding the ubiquitously expressed and multifunctional Yin Yang 1 transcription factor - as responsible. To confirm this hypothesis, we used a Cre/lox strategy to produce mutant mice in which Yy1 expression was ablated in Nav 1.8-positive neurons of the dorsal root ganglion. These mutants also displayed reduced inflammatory pain sensitivity on the formalin test. Further testing of pain-related phenotypes in these mutants revealed robustly increased sensitivity to systemic and spinal (but not supraspinal) morphine analgesia, and greatly increased endogenous (swim stress-induced) opioid analgesia. None of the known biological roles of Yin Yang 1 were suggestive of such a phenotype, and thus a novel player in pain modulatory systems has been identified.


Asunto(s)
Analgesia , Analgésicos Opioides/uso terapéutico , Morfina/uso terapéutico , Nocicepción , Dolor/genética , Factor de Transcripción YY1/genética , Animales , Células Cultivadas , Formaldehído/toxicidad , Ganglios Espinales/citología , Ratones , Ratones Endogámicos C57BL , Mutación , Canal de Sodio Activado por Voltaje NAV1.8/genética , Canal de Sodio Activado por Voltaje NAV1.8/metabolismo , Neuronas/metabolismo , Neuronas/fisiología , Dolor/tratamiento farmacológico , Dolor/etiología , Fenotipo
2.
Neuroscience ; 152(4): 1086-92, 2008 Apr 09.
Artículo en Inglés | MEDLINE | ID: mdl-18358622

RESUMEN

We have previously shown that the atypical methylxanthine, propentofylline, reduces mechanical allodynia after peripheral nerve transection in a rodent model of neuropathy. In the present study, we sought to determine whether propentofylline-induced glial modulation alters spinal glutamate transporters, glutamate transporter-1 (GLT-1) and glutamate-aspartate transporter (GLAST) in vivo, which may contribute to reduced behavioral hypersensitivity after nerve injury. In order to specifically examine the expression of the spinal glutamate transporters, a novel line of double transgenic GLT-1-enhanced green fluorescent protein (eGFP)/GLAST-Discosoma Red (DsRed) promoter mice was used. Adult mice received propentofylline (10 mg/kg) or saline via i.p. injection starting 1 h prior to L5-spinal nerve transection and then daily for 12 days. Mice receiving saline exhibited punctate expression of both eGFP (GLT-1 promoter activation) and DsRed (GLAST promoter activation) in the dorsal horn of the spinal cord, which was decreased ipsilateral to nerve injury on day 12. Propentofylline administration reinstated promoter activation on the injured side as evidenced by an equal number of eGFP (GLT-1) and DsRed (GLAST) puncta in both dorsal horns. As demonstrated in previous studies, propentofylline induced a concomitant reversal of L5 spinal nerve transection-induced expression of glial fibrillary acidic protein (GFAP). The ability of propentofylline to alter glial glutamate transporters highlights the importance of controlling aberrant glial activation in neuropathic pain and suggests one possible mechanism for the anti-allodynic action of this drug.


Asunto(s)
Astrocitos/efectos de los fármacos , Transportador 1 de Aminoácidos Excitadores/metabolismo , Fármacos Neuroprotectores/farmacología , Traumatismos de la Médula Espinal/patología , Xantinas/farmacología , Animales , Transportador 1 de Aminoácidos Excitadores/genética , Transportador 2 de Aminoácidos Excitadores/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Proteína Ácida Fibrilar de la Glía/metabolismo , Hiperalgesia/fisiopatología , Hiperalgesia/prevención & control , Indoles , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Factores de Tiempo
3.
Neuroscience ; 138(2): 601-8, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16413124

RESUMEN

Sex differences in the magnitude of response to thermal and tactile stimuli have been demonstrated in both clinical and animal studies. Female rats typically display lower thresholds to painful stimuli and display more robust responses following nerve injury as compared with males. There is a body of evidence implicating the sex hormones in mediating this sex difference. In the present study, we sought to determine which gonadal hormones were involved in mediating the observed female hypersensitivity in female rats both prior to and following experimental nerve root injury using a chronic hormone replacement paradigm. Female rats were ovariectomized and hormone pellets containing 17beta-estradiol, progesterone (P), 17beta-estradiol+progesterone or placebo were implanted s.c. Our results demonstrate that only the group of female rats that received progesterone alone maintained the hypersensitive phenotype following ovariectomy, compared with gonadally intact male rats. This result was observed both in response to thermal stimuli in non-injured female rats and to thermal and tactile stimuli following L5 nerve root ligation, a model of low back pain associated with lumbar radiculopathy. Postmortem analysis of serum gonadal hormone concentrations demonstrates that the hormonal manipulations were successful and the exogenous hormones were similar to physiological levels observed in the sham-ovariectomized controls. Taken together, these results demonstrate the critical role for progesterone in mediating enhanced female tactile and thermal hypersensitivity following L5 nerve root ligation.


Asunto(s)
Estradiol/farmacología , Terapia de Reemplazo de Estrógeno , Calor , Progesterona/farmacología , Raíces Nerviosas Espinales/fisiología , Tacto/fisiología , Animales , Femenino , Masculino , Ovariectomía , Ratas , Ratas Sprague-Dawley , Raíces Nerviosas Espinales/efectos de los fármacos , Tacto/efectos de los fármacos
4.
J Pharmacol Exp Ther ; 313(3): 1239-47, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15743926

RESUMEN

Glial cells function in maintenance of homeostasis as well as in pathophysiology. In this study, we determined the time course of spinal glial cell activation during the development of morphine analgesic tolerance in an L5 spinal nerve transection rodent model of neuropathic pain. We also sought to assess whether the method of morphine administration affected neuroimmune activation at the levels of transcription and translation. Rats received L5 spinal nerve transection or no surgery on day 0. On day 6 post-transection, osmotic minipumps were implanted to deliver saline or morphine s.c. (1 or 10 mg/kg) or i.t. (5 or 20 nmol/h). Mechanical allodynia developed immediately after spinal nerve transection; this hypersensitivity was reversed with both low- and high-dose morphine by either route. Tolerance to antiallodynia developed after 3 days of i.t. morphine and after 6 days of s.c. morphine, indicating hastened tolerance following i.t. delivery. Analysis of mRNA revealed that s.c. morphine treatment did not lead to increases in glial activation markers. In contrast, i.t. morphine caused a biphasic alteration in glial fibrillary acidic protein (GFAP) and integrin alpha M mRNA. Protein levels for GFAP were elevated after s.c. and i.t. administration of morphine; however, induction was further enhanced in the latter group. Here, we show for the first time that there is differential recruitment of transcriptional and translational mechanisms of glial activation by systemic and i.t. morphine. Furthermore, we suggest that enhanced neuroimmune activation after i.t. dosing contributes to the hastened development of analgesic tolerance seen in these animals.


Asunto(s)
Proteína Ácida Fibrilar de la Glía/genética , Antígeno de Macrófago-1/genética , Morfina/farmacología , Neuroglía/efectos de los fármacos , Dolor/tratamiento farmacológico , Biosíntesis de Proteínas , Transcripción Genética , Animales , Relación Dosis-Respuesta a Droga , Inyecciones Espinales , Inyecciones Subcutáneas , Masculino , Morfina/administración & dosificación , Neuroglía/metabolismo , Ratas , Ratas Sprague-Dawley , Trastornos Relacionados con Sustancias
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA